- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Tezacaftor
Total 70 results
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Canada
-
Charite University, Berlin, GermanyHannover Medical School; Heidelberg University; University of GiessenRecruiting
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Australia, Belgium, Netherlands
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Spain, Ireland, Belgium, Netherlands, United Kingdom, Australia, France, Canada, Denmark, Germany, Italy, Israel
-
Vertex Pharmaceuticals IncorporatedActive, not recruiting
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Netherlands, United Kingdom, Germany, Portugal
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisBelgium, United Kingdom, Australia, Germany
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Belgium, Netherlands, United Kingdom
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States
-
Vertex Pharmaceuticals IncorporatedEnrolling by invitationCystic FibrosisUnited States, Australia, Germany, Sweden, Switzerland, France, Netherlands, United Kingdom
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Spain, Australia, United Kingdom, Germany, Ireland
-
Vertex Pharmaceuticals IncorporatedActive, not recruitingCystic FibrosisUnited States, Australia, Germany, Sweden, Switzerland, France, Netherlands, United Kingdom
-
Vertex Pharmaceuticals IncorporatedActive, not recruitingCystic FibrosisUnited States, Spain, United Kingdom, Belgium, Netherlands, Denmark, Israel, New Zealand, France, Australia, Ireland, Germany, Sweden, Canada, Czechia, Switzerland, Portugal, Italy, Austria, Hungary, Norway, Poland, Greece
-
Vertex Pharmaceuticals IncorporatedApproved for marketing
-
Jennifer Taylor-CousarCystic Fibrosis FoundationRecruiting
-
University of British ColumbiaRecruiting
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Australia, Canada, United Kingdom, Germany, Belgium, Austria, Ireland, Italy, France
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Israel, Ireland, United Kingdom
-
Emory UniversityNational Heart, Lung, and Blood Institute (NHLBI); Cystic Fibrosis FoundationRecruiting
-
University of Erlangen-Nürnberg Medical SchoolRecruitingCystic FibrosisGermany
-
University of British ColumbiaRecruiting
-
University Hospital, Strasbourg, FranceNot yet recruiting
-
Nottingham University Hospitals NHS TrustActive, not recruitingCystic FibrosisUnited Kingdom
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited Kingdom
-
Emory UniversityThe Marcus Foundation, Inc.RecruitingNon-cystic Fibrosis BronchiectasisUnited States
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, France, Germany
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Germany, United Kingdom, Canada, Australia, Switzerland, France, Ireland, Belgium, Denmark, Poland
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Australia, Canada, France, United Kingdom, Germany, Spain, Switzerland, Belgium, Israel, Netherlands, Denmark, Italy, Austria, Ireland, Sweden
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Canada, United Kingdom, Australia, Spain, Germany, Italy, Austria, Belgium, Denmark
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Spain, United Kingdom, New Zealand, Israel, Australia, Ireland, Germany, Sweden, Czechia, Portugal, Hungary
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited Kingdom, France, Germany, Australia, Switzerland, Ireland, Belgium, Denmark, Poland
-
Vertex Pharmaceuticals IncorporatedActive, not recruitingCystic FibrosisUnited States, United Kingdom, Canada, Australia, Germany
-
Vertex Pharmaceuticals IncorporatedApproved for marketing
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, United Kingdom, Belgium, Netherlands, France, Denmark, Israel, New Zealand, Australia, Ireland, Sweden, Canada, Germany, Poland, Switzerland, Italy, Austria, Hungary, Greece, Norway
-
Vertex Pharmaceuticals IncorporatedNot yet recruiting
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisSpain, Belgium, Australia, Canada, Czechia
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisBelgium, Spain, Australia, Canada
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, United Kingdom, Canada, Australia, Germany
-
Vertex Pharmaceuticals IncorporatedRecruitingCystic FibrosisUnited Kingdom, Canada, Switzerland, Australia
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisCanada, France, United Kingdom, Israel, Australia, Spain, Germany, Netherlands, Denmark, Switzerland
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Spain, Ireland, Belgium, Netherlands, United Kingdom, Australia, France, Denmark, Germany, Italy, Canada
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Spain, Ireland, Israel, Australia, United Kingdom, Germany, Canada, Denmark, Poland, Switzerland
-
Sonya HeltsheUniversity of Alabama at Birmingham; University of Washington; Cystic Fibrosis...Recruiting
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Canada, Australia, Ireland, United Kingdom